ReneeK. S.Safe air travel: Preventing in-flight medical problems. Nurse Practitioner, 1994, 1939–46.
2.
CumminsR.O., ChapmanP. J. C., ChamberlainD.A., SchubachJ.A. and LitwinP.E., In-flight deaths during commercial air travel. JAMA, 1988, 2591983–1988.
3.
CumminsR. O. and SchubachJ. A.Frequency and types of medical emergencies among commercial air travelers. JAMA, 1989, 2611295–1299.
4.
LandgrafH., VanselowB., Schultz-HuermannD., MulmannM. V. and BergauL., Economy Class Syndrome: Rheology, fluid balance, and lower leg edema during a simulated 12-hour long distance flight. Aviation Space and Environmental Medicine, 1994, 930–935.
5.
EklofB.O., KistnerR.L., MasudaE.M., SonntagB.V. and WongH.P., Venous thromboembolism in association with prolonged air travel. Dermatological Surgery, 1996, 22637–641.
6.
ForbesC. D. and JohnstonR. V., Venous and arterial thrombosis in airline passengers. Journal of the Royal Society of Medicine, 1998, 565–566.
7.
CapriniJ. A., ArcelusJ. I., MotkieG. D., ZebalaL. P., LeeC. E., FinkeN. M., TamhaneA. and ReynaJ. J., Risk factor assessment in the management of patients with suspected deep vein thrombosis. International Angiology, in press.
8.
RidkerP.M., MiletichJ.P., StampferM.J., GoldhaberS.Z., LindpainterK. and HennekensC.H., Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation, 1995, 922800–2802.
9.
RosendaalF.R., KosterT., VandenbrouckeJ.P. and ReitsmaP.H., High risk of thrombosis in patients homozygous for Factor V Leiden (activated protein C resistance). Blood, 1995, 851504–1508.
10.
PoortS.R., RosendaalF.R., ReitsmaP.H. and BertinaR.M., A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996, 883698–3703.
11.
HessnerM.J., LuhmR.A., PearsonS.L., EndeanD.J., FriedmanK.D. and MontgomeryR.R., Prevalence of prothrombin G20210A Factor VG1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiple allele-specific PCR. Thrombosis Haemostasis, 1999, 81733–738.
12.
AMA Commission on Emergency Medical Services/Medical Aspects of Transportation Aboard Commercial Aircraft. JAMA, 1982, 2471007–1011.
13.
GertlerJ.P., LelandP., L'ItalienG., Chung-WelchN., CambriaR.P., OrkinR. and AbbottW.M., Ambient oxygen tension modulates endothelial fibrinolysis. Journal of Vascular Surgery, 1993, 18939–946.
14.
MilneR., Venous thromboembolism and travel: Is there an association. Journal of the Royal College of Physicians of London, 1992, 2647–19.
15.
Coleridge-SmithP. D., HastyJ. H. and ScurrJ. H.Venous stasis and vein lumen changes during surgery. British Journal of Surgery, 1990, 771055–1059.
16.
ComerotaA. J., StewartG. J. and WhiteJ. V.Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action. American Journal of Surgery, 1995, 150 (4A) 39–44.
17.
CruickshankJ. M., GorlinR. and JennettB.Air travel and thrombotic episodes: The Economy Class Syndrome. Lancet, 1988, ii497–498.
18.
ClaggettG. P., AndersonF. A.Jr., GeertsW., HeitJ. A., KnudsonM., LiebermanJ. R., MerliG. J. and WheelerH. B., Prevention of venous thromboembolism. Chest, 1998, 114531S–560S.
19.
FordyceM. J. and LingR. S.A venous foot pump reduces thrombosis after total hip replacement. Journal of Bone and Joint Surgery, 1992, 7445–49.
20.
SantoriF. S., VitulloA., StopponiM., SantoriN. and GheraS., Prophylaxis against deep-vein thrombosis in total hip replacement: comparison of heparin and foot impulse pump. Journal of Bone and Joint Surgery, 1994, 76579–583.